Two novel variants in DYRK1B causative of AOMS3: expanding the clinical spectrum

• Published in: Orphanet journal of rare diseases Vol. 16; no. 1; pp. 1 - 291
• Main Authors: Mendoza-Caamal, Elvia C, Barajas-Olmos, Francisco, Mirzaeicheshmeh, Elaheh, Ilizaliturri-Flores, Ian, Aguilar-Salinas, Carlos A, Gómez-Velasco, Donaji V, Cicerón-Arellano, Isabel, Reséndiz-Rodríguez, Adriana, Martínez-Hernández, Angélica, Contreras-Cubas, Cecilia, Islas-Andrade, Sergio, Zerrweck, Carlos, García-Ortiz, Humberto, Orozco, Lorena
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 30.06.2021; BioMed Central; BMC
• Subjects: Abdomen; Age; AOMS3; Body mass index; Cardiovascular disease; Causes of; Children; Coronary vessels; Creatinine; Diabetes; Diabetes mellitus (non-insulin dependent); DYRK1B; Exons; Family medical history; Genes; Genetic aspects; Genetic variation; Genotypes; Glucose; Heredity; Hydrogen bonds; Hypertension; Hypertriglyceridemia; Insulin; Insulin resistance; Kinases; Medical research; Medicine, Experimental; Metabolic disorders; Metabolic syndrome; Metabolic syndrome X; Metabolism, Inborn errors of; Monogenic, and Obesity; Mutation; Obesity; Pathogenesis; Phenotypes; Phosphatase; Rare diseases; Transcription factors; Mexico
• ISSN: 1750-1172; 1750-1172
• DOI: 10.1186/s13023-021-01924-z

We investigated pathogenic DYRK1B variants causative of abdominal obesity-metabolic syndrome 3 (AOMS3) in a group of patients originally diagnosed with type 2 diabetes. All DYRK1B exons were analyzed in a sample of 509 unrelated adults with type 2 diabetes and 459 controls, all belonging to the DMS1 SIGMA-cohort (ExAC). We performed in silico analysis on missense variants using Variant Effect Predictor software. To evaluate co-segregation, predicted pathogenic variants were genotyped in other family members. We performed molecular dynamics analysis for the co-segregating variants. After filtering, Mendelian genotypes were confirmed in two probands bearing two novel variants, p.Arg252His and p.Lys68Gln. Both variants co-segregated with the AOMS3 phenotype in classic dominant autosomal inheritance with full penetrance. In silico analysis revealed impairment of the DYRK1B protein function by both variants. For the first time, we describe age-dependent variable expressivity of this entity, with central obesity and insulin resistance apparent in childhood; morbid obesity, severe hypertriglyceridemia, and labile type 2 diabetes appearing before 40 years of age; and hypertension emerging in the fifth decade of life. We also report the two youngest individuals suffering from AOMS3. Monogenic forms of metabolic diseases could be misdiagnosed and should be suspected in families with several affected members and early-onset metabolic phenotypes that are difficult to control. Early diagnostic strategies and medical interventions, even before symptoms or complications appear, could be useful.